Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 3 results:
Author Title Type [ Year(Asc)]
Filters: Author is Bui, C. L.  [Clear All Filters]
2020
A. Arana, Margulis, A. V., Varas-Lorenzo, C., Bui, C. L., Gilsenan, A., McQuay, L. J., Reynolds, M., Rebordosa, C., Franks, B., de Vogel, S., Appenteng, K., and Perez-Gutthann, S., “Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom”, Pharmacoepidemiol Drug Saf, 2020.
2018
A. V. Margulis, Linder, M., Arana, A., Pottegard, A., Berglind, I. A., Bui, C. L., Kristiansen, N. S., Bahmanyar, S., McQuay, L. J., Atsma, W. J., Appenteng, K., D'Silva, M., Perez-Gutthann, S., and Hallas, J., “Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom”, PLoS One, vol. 13, p. e0204456, 2018.
2017
J. A. Kaye, Margulis, A. V., Fortuny, J., McQuay, L. J., Plana, E., Bartsch, J. L., Bui, C. L., Perez-Gutthann, S., and Arana, A., “Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias”, Pharmacotherapy, vol. 37, pp. 673-683, 2017.
[Page last reviewed 6 April 2021]